Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · IEX Real-Time Price · USD
5.07
+0.17 (3.47%)
At close: Mar 28, 2024, 4:00 PM
5.17
+0.10 (1.97%)
After-hours: Mar 28, 2024, 7:09 PM EDT
BDTX Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for BDTX stock have an average target of 10.75, with a low estimate of 10 and a high estimate of 12. The average target predicts an increase of 112.03% from the current stock price of 5.07.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for BDTX stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Oct '23 | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 → $12 | Strong Buy | Reiterates | $11 → $12 | +136.69% | Mar 18, 2024 |
Wedbush | Wedbush | Buy Reiterates $10 | Buy | Reiterates | $10 | +97.24% | Mar 13, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +116.96% | Nov 22, 2023 |
Wedbush | Wedbush | Buy Reiterates $10 | Buy | Reiterates | $10 | +97.24% | Sep 12, 2023 |
Piper Sandler | Piper Sandler | Buy Initiates $11 | Buy | Initiates | $11 | +116.96% | Jul 14, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.13
from -1.88
EPS Next Year
-2.25
from -2.13
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | n/a | 35.3M | 161.5M | 325.6M |
Avg | n/a | n/a | 14.2M | 74.3M | 178.0M |
Low | n/a | n/a | n/a | 11.8M | 63.7M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | 1,038.4% | 338.1% |
Avg | - | - | - | 423.8% | 139.6% |
Low | - | - | - | -17.1% | -14.3% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -2.05 | -2.03 | -1.65 | -0.24 | 1.12 |
Avg | -2.13 | -2.25 | -2.41 | -1.45 | 0.19 |
Low | -2.13 | -2.48 | -3.52 | -3.28 | -1.13 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.